BASFY

BASF SE ADR

Price

$15.61

return (12m)

25.06%

p/e

8.03

p/bv

1.25

DIVIDEND YIELD

2.95%

BASFY price

BASF SE ADR

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BASFY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

5.26%

3 months

11.02%

1 year

25.06%

2 years

40.55%

5 years

9.58%

10 years

29.20%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals BASFY

Valuation

P/E

8.03

Sector 7.77

Industry 7.77

P/BV

1.25

Sector 1.90

Industry 1.90

P/Revenue (PSR)

0.75

Sector 1.84

Industry 1.84

EV/EBITDA

28.00

Sector -302.20

Industry -302.20

EV/EBIT

56.21

Sector -33,455,055.77

Industry -33,455,055.77

P/EBITDA

5.61

Sector -5.49

Industry -5.49

P/EBIT

11.32

Sector -6.67

Industry -6.67

P/Total Assets

0.56

Sector 0.89

Industry 0.89

P/Net Current Assets

-6.08

Sector -2.12

Industry -2.12

P/Working Capital

2.61

Sector -4,903.85

Industry -4,903.85

EPS

1.93

Sector 0.73

Industry 0.73

BVPS

12.42

Sector 9.99

Industry 9.99

Efficiency

Gross Margin

23.94%

Sector 35.23%

Industry 35.23%

EBITDA Margin

11.97%

Sector -6,811,851.86%

Industry -6,811,851.86%

EBIT Margin

5.96%

Sector -6.18%

Industry -6.18%

Operating Margin

5.05%

Sector 4.26%

Industry 4.26%

Net Profit Margins

9.36%

Sector 2.64%

Industry 2.64%

Asset Turnover

0.21

Sector 0.11

Industry 0.11

Profitability

ROE

15.56%

Sector 2.38%

Industry 2.38%

ROA

6.94%

Sector -0.64%

Industry -0.64%

ROIC

3.82%

Sector -114.63%

Industry -114.63%

Dividends

Dividend yield

2.95%

Sector 0.50%

Industry 0.50%

Payout

23.69%

Sector 9.88%

Industry 9.88%

Debt

Current Ratio

1.85

Sector 1.45

Industry 1.45

Net Debt / EBITDA

5.31

Sector -19.92

Industry -19.92

Net Debt / EBIT

10.66

Sector -212,542,660.62

Industry -212,542,660.62

Net Debt / Equity

0.29

Sector -0.57

Industry -0.57

Gross Debt / Equity

0.50

Sector -0.50

Industry -0.50

Equity/Assets

0.45

Sector 0.43

Industry 0.43

Liabilities/Assets

0.55

Sector 0.53

Industry 0.53

Growth

5Y Revenue CAGR

-4.97%

Sector -

Industry -

5Y Earnings CAGR

0.54%

Sector -

Industry -

Fundamentals BASFY

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF BASF SE ADR ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$15.61

Fair Value

$23.22

Upside Return potential.

48.77%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

BASFY Historical Dividends

current DY: 2.95%

5-year average DY: 7.77%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	05/04/2026	05/18/2026	0.45830000
Dividends	05/05/2025	05/19/2025	0.63010000
Dividends	04/25/2024	05/10/2024	0.92300000
Dividends	04/28/2023	05/08/2023	0.89900000
Dividends	04/29/2022	05/16/2022	0.93300000
Dividends	04/29/2021	05/14/2021	0.98000000
Dividends	06/18/2020	07/06/2020	0.93200000
Dividends	05/03/2019	05/20/2019	0.90200000
Dividends	05/04/2018	05/21/2018	0.94400000
Dividends	05/15/2017	05/24/2017	0.79875000
Dividends	04/27/2016	05/09/2016	0.83975000
Dividends	04/28/2015	05/11/2015	0.74050000
Dividends	04/30/2014	05/12/2014	0.92950000
Dividends	04/24/2013	05/06/2013	0.84275000
Dividends	04/25/2012	05/04/2012	0.82450000
Dividends	05/04/2011	05/19/2011	0.76475000
Dividends	04/27/2010	05/10/2010	0.57425000
Dividends	04/28/2009	05/14/2009	0.63325000
Dividends	04/22/2008	05/05/2008	0.76137500
Dividends	04/24/2007	05/07/2007	0.49875000
Dividends	05/02/2006	05/15/2006	0.29787500
Dividends	04/26/2005	05/09/2005	0.28400000
Dividends	04/27/2004	05/10/2004	0.21525000
Dividends	05/02/2003	05/19/2003	0.19275000
Dividends	04/26/2002	05/13/2002	0.14225000
Dividends	04/24/2001	05/03/2001	0.23325000

ABOUT BASF SE ADR

BASF SE ADR

Average Investor10 user rating

1.0 (25 people)

Germany

- year

Founded:

1988

Time since IPO - 38 years

94.910

Employees

Solventum Corporation operates in the healthcare sector within the medical technology and healthcare solutions industry. The company was created through the spin-off of 3M’s healthcare business, focusing on medical technologies, clinical solutions and healthcare management systems.

Solventum develops products and technologies designed to support hospitals, healthcare professionals and clinical laboratories.

Its main areas of activity include:

• Medical devices and healthcare products used in hospital and clinical environments.
• Dental and oral care technologies for professional dental practices.
• Infection prevention and sterilization solutions used in healthcare facilities.
• Healthcare data and analytics platforms supporting clinical documentation and hospital management.

The company serves healthcare providers such as hospitals, clinics, laboratories and dental practices, offering products and software solutions aimed at improving clinical efficiency and patient safety.

Solventum maintains operations across North America, Europe and Asia, supported by research centers, manufacturing facilities and global distribution networks.

Industry dynamics affecting the company include regulatory requirements for medical technologies, digital transformation in healthcare, advances in medical devices and increasing demand for healthcare efficiency and data-driven clinical systems.

Shares of Solventum Corporation trade on Nasdaq under the ticker SOLV.

History and Development

Solventum Corporation was established in 2024 in the United States following the spin-off of 3M’s healthcare division, which had historically developed a wide range of medical technologies and clinical solutions.

The separation was announced in 2022, with the objective of creating an independent company dedicated exclusively to healthcare innovation and medical technologies.

Following the spin-off, Solventum focused on building its independent operational structure while maintaining the product portfolio and technologies previously developed within 3M’s healthcare business.

In 2024, the company became publicly listed on Nasdaq, marking the beginning of its operations as a standalone publicly traded healthcare technology company.

Since its creation, Solventum has continued investing in research, automation and digital healthcare technologies, focusing on medical devices, clinical data systems and healthcare solutions designed to improve operational efficiency in healthcare institutions.

Additional Information

BASF SE ADR (Germany) is listed on the Nasdaq and has a market capitalization of $53.84 billion, with shareholders equity totaling $43.08 billion.

The company employs approximately 94.910 people and operates in the Others sector, within the Others industry.

Over the past 12 months, BASF SE ADR reported $71.59 billion in revenue, generating net income of $6.70 billion.

Key financial metrics include a P/E ratio of 8.03, a price-to-book (P/B) ratio of 1.25, and a trailing twelve-month dividend yield of 2.95%.

The company trades under the ticker BASFY.

Market cap

$53.84 billion

Net worth

$43.08 billion

$43,082,950,000.00

Assets

$96.62 billion

$96,620,970,000.00

Total Shares Outstanding

3.47 billion

3,469,000,000

Average Daily Trading Volume

$145.31 Thousand

$145,309.22

Sector

Others

Industry

Others

BASFY

revenue by Business Segment BASF SE ADR

Revenue by Region BASF SE ADR

BASFY revenue and profits

Financial Results BASFY

DRAG THE FRAME TO SEE MORE DATA

BASFY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$396.89 27,99% (12M)

P/E

23.91

2.26%

ROE

14.27%

P/BV

3.41

SHEL - Shell PLC ADR

$94.86 38,57% (12M)

P/E

9.97

3.19%

ROE

14.29%

P/BV

1.42

STLA - Stellantis NV

$5.42 --39,56% (12M)

P/E

-0.63

0.00%

ROE

-35.93%

P/BV

0.23

COR - Cencora Inc.

$330.95 11,95% (12M)

P/E

24.46

0.72%

ROE

81.48%

P/BV

19.93

ALIZY - Allianz SE ADR

$52.20 --7,24% (12M)

P/E

14.43

2.60%

ROE

17.89%

P/BV

2.58

TTE - TotalEnergies SE ADR

$90.15 59,81% (12M)

P/E

7.11

4.58%

ROE

21.42%

P/BV

1.52

NSRGY - Nestle SA ADR

$99.09 9,78% (12M)

P/E

11.62

4.14%

ROE

58.05%

P/BV

6.75

ELV - Elevance Health Inc

$400.93 33,41% (12M)

P/E

19.53

1.73%

ROE

9.84%

P/BV

1.92